Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile

A series of sulfamide fragments has been synthesised and investigated for human carbonic anhydrase inhibition. One of the fragments showing greater selectivity for cancer-related isoforms hCA IX and XII was co-crystalized with hCA II showing significant potential for fragment periphery evolution via...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharonova, Tatiana, Zhmurov, Petr, Kalinin, Stanislav, Nocentini, Alessio, Angeli, Andrea, Ferraroni, Marta, Korsakov, Mikhail, Supuran, Claudiu T., Krasavin, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933014/
https://www.ncbi.nlm.nih.gov/pubmed/35296197
http://dx.doi.org/10.1080/14756366.2022.2051023
_version_ 1784671551248924672
author Sharonova, Tatiana
Zhmurov, Petr
Kalinin, Stanislav
Nocentini, Alessio
Angeli, Andrea
Ferraroni, Marta
Korsakov, Mikhail
Supuran, Claudiu T.
Krasavin, Mikhail
author_facet Sharonova, Tatiana
Zhmurov, Petr
Kalinin, Stanislav
Nocentini, Alessio
Angeli, Andrea
Ferraroni, Marta
Korsakov, Mikhail
Supuran, Claudiu T.
Krasavin, Mikhail
author_sort Sharonova, Tatiana
collection PubMed
description A series of sulfamide fragments has been synthesised and investigated for human carbonic anhydrase inhibition. One of the fragments showing greater selectivity for cancer-related isoforms hCA IX and XII was co-crystalized with hCA II showing significant potential for fragment periphery evolution via fragment growth and linking. These opportunities will be identified in the future via the screening of this fragment structure for co-operative carbonic anhydrase binding with other structurally diverse fragments. [Figure: see text]
format Online
Article
Text
id pubmed-8933014
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-89330142022-03-19 Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile Sharonova, Tatiana Zhmurov, Petr Kalinin, Stanislav Nocentini, Alessio Angeli, Andrea Ferraroni, Marta Korsakov, Mikhail Supuran, Claudiu T. Krasavin, Mikhail J Enzyme Inhib Med Chem Short Communication A series of sulfamide fragments has been synthesised and investigated for human carbonic anhydrase inhibition. One of the fragments showing greater selectivity for cancer-related isoforms hCA IX and XII was co-crystalized with hCA II showing significant potential for fragment periphery evolution via fragment growth and linking. These opportunities will be identified in the future via the screening of this fragment structure for co-operative carbonic anhydrase binding with other structurally diverse fragments. [Figure: see text] Taylor & Francis 2022-03-16 /pmc/articles/PMC8933014/ /pubmed/35296197 http://dx.doi.org/10.1080/14756366.2022.2051023 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Sharonova, Tatiana
Zhmurov, Petr
Kalinin, Stanislav
Nocentini, Alessio
Angeli, Andrea
Ferraroni, Marta
Korsakov, Mikhail
Supuran, Claudiu T.
Krasavin, Mikhail
Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
title Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
title_full Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
title_fullStr Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
title_full_unstemmed Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
title_short Diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
title_sort diversely substituted sulfamides for fragment-based drug discovery of carbonic anhydrase inhibitors: synthesis and inhibitory profile
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933014/
https://www.ncbi.nlm.nih.gov/pubmed/35296197
http://dx.doi.org/10.1080/14756366.2022.2051023
work_keys_str_mv AT sharonovatatiana diverselysubstitutedsulfamidesforfragmentbaseddrugdiscoveryofcarbonicanhydraseinhibitorssynthesisandinhibitoryprofile
AT zhmurovpetr diverselysubstitutedsulfamidesforfragmentbaseddrugdiscoveryofcarbonicanhydraseinhibitorssynthesisandinhibitoryprofile
AT kalininstanislav diverselysubstitutedsulfamidesforfragmentbaseddrugdiscoveryofcarbonicanhydraseinhibitorssynthesisandinhibitoryprofile
AT nocentinialessio diverselysubstitutedsulfamidesforfragmentbaseddrugdiscoveryofcarbonicanhydraseinhibitorssynthesisandinhibitoryprofile
AT angeliandrea diverselysubstitutedsulfamidesforfragmentbaseddrugdiscoveryofcarbonicanhydraseinhibitorssynthesisandinhibitoryprofile
AT ferraronimarta diverselysubstitutedsulfamidesforfragmentbaseddrugdiscoveryofcarbonicanhydraseinhibitorssynthesisandinhibitoryprofile
AT korsakovmikhail diverselysubstitutedsulfamidesforfragmentbaseddrugdiscoveryofcarbonicanhydraseinhibitorssynthesisandinhibitoryprofile
AT supuranclaudiut diverselysubstitutedsulfamidesforfragmentbaseddrugdiscoveryofcarbonicanhydraseinhibitorssynthesisandinhibitoryprofile
AT krasavinmikhail diverselysubstitutedsulfamidesforfragmentbaseddrugdiscoveryofcarbonicanhydraseinhibitorssynthesisandinhibitoryprofile

Ejemplares similares